CVC’s €10.7bn Recordati Bid Faces Revolt

CVC has put forward a €10.7bn proposal to take Recordati (RECm) private, marking a major potential transaction in the European pharmaceuticals sector. The offer, structured as a take-private deal, would remove Recordati from the public markets if completed. The size of the proposal underscores Recordati’s strategic value and the scale of capital CVC is prepared to deploy to secure control.

The plan centers on acquiring sufficient shares in Recordati to complete the take-private process. For such transactions, the stance of existing shareholders is critical, as their approval and participation determine whether the offer can reach the necessary thresholds. Against this backdrop, the reaction from Recordati’s investor base has become the focal point for the deal’s prospects.

Reports indicate that CVC now faces a shareholder revolt over its €10.7bn proposal. A segment of Recordati’s shareholders is described as opposing the transaction, raising questions about the level of support for the bid. This resistance suggests that agreement among investors cannot be taken for granted and that CVC may encounter obstacles in securing the required backing.

The reported revolt highlights a gap between CVC’s plans and the expectations or preferences of at least some shareholders. In contested situations of this kind, investors can influence the outcome by withholding support, seeking changes to the proposal, or pushing for alternative options. This dynamic now appears central to how the Recordati transaction will evolve.

The emergence of organized shareholder opposition introduces significant uncertainty around the €10.7bn take-private plan. Without broad investor alignment, it may be difficult for CVC to complete the transaction on the current terms and timeline. The reported pushback effectively places the deal under pressure and could force reassessment of how to move forward.

For Recordati, the situation means that ownership and listing status remain unresolved while the proposal is contested. The balance of power now lies with shareholders whose decisions will determine whether the company stays public or transitions into private ownership under CVC. Until that is clarified, both parties face an unsettled outlook around one of the largest potential deals involving the company.